Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-10-13

Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Etravirine Administered in Combination With Other Antiretroviral Agents in Antiretroviral Treatment-Experienced HIV-1 Infected Patients [Phase 4]

View source ↗

Summary

Phase 4 study evaluating the safety, tolerability, and pharmacokinetics of etravirine in combination with other antiretroviral agents in ART-experienced HIV-1 i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Intelence (Etravirine)

Snippet

Sponsor: Janssen R&D Ireland | Conditions: Human Immunodeficiency Virus (HIV) Infection | Phase 4 | Status: COMPLETED